GlassScriptPhysician profile
Charles R Vincent
NPI 1497845283
$4,185.69
in general payments reported to CMS, 2019-2025
40 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $118 · 2021: $528 · 2022: $739 · 2023: $954 · 2024: $927 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,617.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $459.06 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $452.96 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $358.26 | 2019-2025 | |
| Astellas Pharma US INC | $212.30 | 2019-2025 | Xtandi, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $202.84 | 2022-2024 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $166.65 | 2021-2022 | |
| Antares Pharma, INC. | $165.30 | 2021-2022 | |
| Abbvie INC. | $162.14 | 2020-2025 | Botox |
| Janssen Biotech, INC. | $160.00 | 2019-2025 | Erleada |
| Merck Sharp & Dohme LLC | $152.54 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $142.72 | 2021-2023 | |
| Medtronic, INC. | $140.08 | 2021-2024 | Interstim |
| 180 Medical, INC. | $138.99 | 2023-2025 | |
| Tolmar, INC. | $124.48 | 2023-2025 | Eligard, Jatenzo |
| Edap Technomed INC | $123.00 | 2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $111.52 | 2020-2022 | |
| Urovant Sciences INC | $89.47 | 2022 | |
| Medtronic USA, INC. | $85.19 | 2019-2020 | |
| Urogen Pharma, INC. | $83.82 | 2021-2025 | Jelmyto |
| Blue Earth Diagnostics | $71.57 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $68.32 | 2022-2023 | Yonsa |
| Becton, Dickinson and Company | $52.45 | 2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $51.98 | 2019-2025 | Ams 700 |
| Accord Healthcare, INC. | $43.95 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $42.07 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $41.32 | 2023-2025 | |
| Axonics, INC. | $30.37 | 2021-2023 | Axonics, Bulkamid |
| Myovant Sciences INC. | $29.53 | 2022 | |
| Convatec INC. | $28.15 | 2021 | |
| Olympus America INC. | $24.18 | 2025 | Itind System |
| Procept Biorobotics Corporation | $21.97 | 2024 | Aquabeam System |
| Calyxo, INC. | $21.19 | 2024 | Cvac Aspiration System |
| Hollister Incorporated | $20.72 | 2023 | Vapro Plus Pocket, Infyna Chic |
| Glaxosmithkline, LLC. | $17.77 | 2019 | |
| Immunitybio, INC. | $16.49 | 2025 | |
| Sagent Pharmaceuticals | $15.47 | 2020 | |
| Teleflex LLC | $15.29 | 2023 | Urolift |
| Amgen INC. | $15.17 | 2019 | |
| Coloplast Corp | $14.43 | 2021 | |
| Allergan, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Vincent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.